Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

43
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
43
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

46
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
46
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

82
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
82
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

28
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
28
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

27
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

48
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
48

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarkers in QuantiFERON Supernatants May Help Distinguish Latent Tuberculosis Infection From Active Tuberculosis: Preliminary Report.

Mediators of inflammation·2026
Same author

Exploring glucocorticoid receptor signalling in lymphangioleiomyomatosis.

ERJ open research·2026
Same author

Long-term outcomes of sirolimus therapy in sporadic and tuberous sclerosis complex-associated lymphangioleiomyomatosis: a retrospective cohort study.

Polish archives of internal medicine·2026
Same author

Acute respiratory failure as a rare presentation of non-fibrotic hypersensitivity pneumonitis: Case series.

Medicine·2026
Same author

Kaposiform lymphangiomatosis-the effects of long-term treatment with sirolimus: case series study and review of the literature.

Frontiers in medicine·2026
Same author

Discovery of a tetrazole-thiourea derivative as a potential active agent against multidrug-resistant Staphylococcus aureus and Mycobacterium tuberculosis.

Pharmacological reports : PR·2026

Related Experiment Video

Updated: Sep 29, 2025

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.6K

Tuberculous Pericarditis-Own Experiences and Recent Recommendations.

Małgorzata Dybowska1, Katarzyna Błasińska2, Juliusz Gątarek3

  • 1Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Poland.

Diagnostics (Basel, Switzerland)
|March 25, 2022
PubMed
Summary

Tuberculous pericarditis (TBP) is a significant cause of pericardial effusion, especially in endemic areas. Early diagnosis and treatment are crucial to prevent severe complications like cardiac tamponade and constrictive pericarditis.

Keywords:
constrictive pericarditisextrapulmonary tuberculosispericarditistuberculous pericarditis

More Related Videos

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.0K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

371

Related Experiment Videos

Last Updated: Sep 29, 2025

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.6K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.0K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

371

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Pulmonology

Background:

  • Tuberculous pericarditis (TBP) represents 1% of all tuberculosis cases and 1-2% of extrapulmonary tuberculosis.
  • TBP is a major cause of effusive pericarditis in endemic regions (50-90%) compared to non-endemic areas (4%).
  • Untreated TBP can lead to severe outcomes including cardiac tamponade, constrictive pericarditis, and mortality.

Purpose of the Study:

  • To summarize current knowledge and clinical experience regarding the diagnostic and therapeutic algorithm for TBP.
  • To emphasize the importance of early diagnosis for effective TBP management.
  • To highlight emerging molecular diagnostic methods for identifying *M. tuberculosis* in pericarditis.

Main Methods:

  • Review of clinical experience and current literature on tuberculous pericarditis.
  • Analysis of diagnostic and therapeutic strategies for TBP.
  • Focus on the application of novel molecular techniques for *M. tuberculosis* detection.

Main Results:

  • Early diagnosis is critical for preventing severe sequelae of TBP.
  • Established diagnostic and therapeutic guidelines are essential for managing TBP.
  • Emerging molecular methods show promise for rapid and accurate confirmation of tuberculous pericarditis.

Conclusions:

  • Prompt diagnosis and effective treatment of TBP are vital to reduce morbidity and mortality.
  • A comprehensive diagnostic and therapeutic approach is necessary for optimal TBP patient outcomes.
  • Advancements in molecular diagnostics are improving the etiological confirmation of pericarditis caused by *M. tuberculosis*.